Swiss National Bank
PRVB

Swiss National Bank’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Swiss National Bank’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-178,800
Closed -$4.31M – 2700
2023
Q1 		$4.31M Sell
178,800
-8,300
-4% -$104K ﹤0.01% 1370
2022
Q4 		$1.98M Buy
187,100
+60,200
+47% +$486K ﹤0.01% 1900
2022
Q3 		$571K Hold
126,900
– – ﹤0.01% 2526
2022
Q2 		$508K Buy
126,900
+14,500
+13% +$68.7K ﹤0.01% 2607
2022
Q1 		$823K Buy
112,400
+7,600
+7% +$45.5K ﹤0.01% 2484
2021
Q4 		$589K Hold
104,800
– – ﹤0.01% 2636
2021
Q3 		$671K Hold
104,800
– – ﹤0.01% 2530
2021
Q2 		$883K Sell
104,800
-2,700
-3% -$21.8K ﹤0.01% 2525
2021
Q1 		$1.13M Buy
107,500
+18,400
+21% +$259K ﹤0.01% 2305
2020
Q4 		$1.51M Buy
89,100
+3,000
+3% +$45K ﹤0.01% 2071
2020
Q3 		$1.1M Hold
86,100
– – ﹤0.01% 2041
2020
Q2 		$1.22M Buy
+86,100
New +$1.09M ﹤0.01% 1993

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Swiss National Bank's PRVB Position: Q2 2023 in Review

Swiss National Bank sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 178,800 shares — an estimated $4.31M sold.

Swiss National Bank first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $4.31M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Swiss National Bank reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 178,800 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $4.31M.
  • Swiss National Bank first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Swiss National Bank's Provention Bio, Inc. Common Stock position peaked at $4.31M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.